Literature DB >> 30138452

Correction: Serum soluble B7-H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma.

.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0199719.].

Entities:  

Year:  2018        PMID: 30138452      PMCID: PMC6107280          DOI: 10.1371/journal.pone.0203174

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Notice of Republication

This article was republished on August 14, 2018, to correct for errors in the Data Availability statement introduced during the production process. The publisher apologizes for the errors. Please download this article again to view the correct version. The originally published, uncorrected article and the republished, corrected articles are provided here for reference.

Originally published, uncorrected article.

(PDF) Click here for additional data file.

Republished, corrected article.

(PDF) Click here for additional data file.
  1 in total

1.  Serum soluble B7-H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma.

Authors:  Takeshi Azuma; Yujiro Sato; Tetsukuni Ohno; Miyuki Azuma; Haruki Kume
Journal:  PLoS One       Date:  2018-07-25       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.